Gamifant: payments to doctors
Payments that named Gamifant as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.1M
- Providers
- 2,034
- Transactions
- 6,675
- Average per transaction
- $618
The per-transaction average — $618 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,034 providers the average total is $2,029, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| SOBI, Inc | $2,914,530 | 70.6% |
| Sobi, Inc | $1,103,195 | 26.7% |
| Swedish Orphan Biovitrum AB | $109,712 | 2.7% |